Journal of Diabetes Investigation: Vol. 17, Issue 2 Review
This issue highlights key advancements in managing diabetes and its complications, focusing on early detection methods, advanced treatment technologies, and personalized medical approaches. Neuropathy remains a core focus, with researchers identifying new, accessible, and objective ways to diagnose early nerve damage. Furthermore, we see how modern automated insulin pumps are significantly raising quality of life for those with type 1 diabetes, and how machine learning is helping clinicians predict which patients will benefit most from specific glucose-lowering therapies.
Key Takeaway: Future diabetes care is shifting towards highly customized treatment plans—utilizing technology and metabolic profiles to optimize patient outcomes.
This article was created with the assistance of AI. Although the content is based on original research articles and other academic sources, errors may be present. Please verify the information using the original articles and consult qualified healthcare professionals for medical advice.
Impact of Glycemic Variability on Early Sweat Gland Dysfunction
Authors: Yang Ou, Xiao‐feng Hu, Zhi Liang, Xiao‐hui Zhang, Yi‐kun Zhou
Research Objective: To investigate how wide fluctuations in blood sugar (glycemic variability) affect sweat gland function in the hands and feet of patients with type 2 diabetes. Impaired sweat function (sudomotor dysfunction) is an early warning sign of diabetic peripheral nerve damage.
Methods: The researchers evaluated 206 patients with type 2 diabetes and 34 healthy individuals. Sweat function in the hands and feet was assessed using special conductivity tests. Diabetes patients also wore continuous glucose monitors (CGMs) to map out blood sugar fluctuations.
Main Findings: Patients with abnormal sweat function typically had diabetes for longer and suffered from wider blood sugar swings. Interestingly, a specific group of patients with "reversible" sweat gland damage showed high sensitivity to blood sugar control; keeping blood sugar levels steady between 5.0 and 10.0 mmol/L was linked with noticeable improvements in their sweat function.
Clinical Significance: Rapidly fluctuating blood sugar levels directly correlate with more severe nerve damage. Keeping blood sugar stable, specifically in the 5–10 mmol/L range, may protect and even restore early-stage nerve function.
Evaluating the Link Between White Blood Cell Counts and Diabetic Retinopathy
Authors: Yan Wang, Yunxian Gao, Zhiqiang Wang, Luhua Wu, Lixia Guo, Xiaoqiang Zhang, Jiaxin Wu, Shanshan Shang
Research Objective: To examine whether circulating white blood cells (leukocytes) play a direct, causal role in the development of diabetic retinopathy, a leading cause of vision loss.
Methods: The study used a sophisticated genetic comparison method called Mendelian randomization, drawing on data from large genomic studies of European populations to assess five types of white blood cells.
Main Findings: The genetic data showed that a higher count of a specific type of white blood cell, lymphocytes, is associated with a lower risk of developing diabetic retinopathy. Other cell types, such as neutrophils and monocytes, did not show a clear, robust causal relationship.
Clinical Significance: This study provides genetic evidence pointing toward the immune system's protective and active role in eye health, helping researchers narrow down specific inflammatory markers for future treatment targets.
Phase IIa Evaluation of ONO-2910 for Diabetic Polyneuropathy
Authors: Yukiko Onishi, Takeshi Osonoi, Norio Takahashi, Toru Takiguchi, Eiichiro Morishima, Yoshimasa Aso, Kenji Sekiguchi, Hideki Kamiya, Jiro Nakamura
Research Objective: To evaluate the safety and clinical effectiveness of ONO-2910, a novel drug candidate designed to support nerve health by promoting helper-cell (Schwann cell) growth, in patients with diabetic polyneuropathy.
Methods: In a double-blinded clinical study, Japanese patients with type 2 diabetes and nerve pain/numbness were randomized to receive either 300 mg of ONO-2910 daily (76 patients) or a placebo (77 patients) for 12 weeks.
Main Findings: The drug was well-tolerated, with side effects being mild and similar to those who took the placebo (such as cold-like symptoms and mild diarrhea). However, after 12 weeks, there were no significant improvements in pain, numbness, or nerve impulse speeds compared to the placebo group.
Clinical Significance: While ONO-2910 has established a strong safety profile, a 12-week regimen did not show a therapeutic advantage over placebo for alleviating nerve symptoms. Future trials may need to explore different timelines or patient subgroups.
Using Machine Learning to Predict Patient Response to Imeglimin
Authors: Katsuhiko Hagi, Kazumasa Yoshida, Hirotaka Watada, Kohei Kaku, Kohjiro Ueki
Research Objective: To identify which patient-specific traits (like age, weight, and cholesterol levels) can predict a strong response to the diabetes medication imeglimin.
Methods: Researchers utilized machine learning algorithms to analyze data from three large clinical trials of imeglimin in Japan, looking at patients who took the drug on its own versus those who added it to existing insulin therapy.
Main Findings: For those taking imeglimin alone, nonsmokers with high baseline HbA1c (≥8.35%) and healthy LDL cholesterol levels achieved the greatest blood sugar drop. For patients taking it alongside insulin, older individuals with a lower BMI and lower liver enzymes (ALT) responded best.
Clinical Significance: This study demonstrates that advanced computing and artificial intelligence can help doctors "match" the right patient with the right medication, leading to better clinical success and highly personalized diabetes management.
How COVID-19 Containment Altered Body Composition in Adults with Diabetes
Authors: Yuko Yamaguchi, Yoshiyuki Hamamoto, Masahiro Imura, Yuichiro Yamada, Yutaka Seino
Research Objective: To observe how lifestyle restrictions, such as Japan's repeated COVID-19 states of emergency, influenced the body weight, muscle mass, and fat mass of people living with diabetes.
Methods: A retrospective study tracked 673 adults with diabetes across three periods: before the states of emergency, during them, and after they were lifted.
Main Findings: While patients' overall HbA1c (blood sugar average) remained remarkably stable, their physical body composition changed. All studied groups showed a continuous loss of skeletal muscle mass. Furthermore, older males experienced an increase in overall body fat percentage because their fat mass did not drop after restrictions ended, while their muscle continued to decline.
Clinical Significance: Prolonged periods of restricted physical activity can trigger "hidden" health risks like muscle loss (sarcopenia) and a rise in body fat percentage, even if your weight or laboratory blood sugar numbers appear stable.
Understanding the Role of PKM2 in Diabetic Kidney Disease and Cell Aging
Authors: Md. Imrul Kayes, Keizo Kanasaki
Research Objective: To review how changes in a specific enzyme called PKM2 (pyruvate kinase M2) affect kidney cell damage and aging (senescence) when exposed to chronic high blood sugar.
Methods: A detailed review of metabolic pathways, tracking how kidney cells process sugar under standard vs. hyperglycemic conditions.
Main Findings: Under long-term high blood sugar, the PKM2 enzyme shifts from its healthy, highly active form (tetramer) to a sluggish form (dimer). This sluggish form causes kidney cells to accumulate lactic acid and triggers cellular stress, inflammation, and cellular aging, which ultimately leads to kidney scarring and tissue damage.
Clinical Significance: Finding ways to stabilize PKM2 back into its healthy tetramer state could protect kidney cells from metabolic stress, offering a brand-new way to slow down or even reverse diabetic kidney disease (DKD).
Upgrading to Advanced Insulin Pumps Improves Daily Treatment Satisfaction
Authors: Naoya Shimizu, Nozomi Ishimoto, Umeko Sakamoto, Mai Taneda, Akinori Hayashi, Takeshi Miyatsuka
Research Objective: To assess whether sequentially upgrading to more advanced, automated insulin pump systems truly increases patient satisfaction and improves overall blood sugar control in people with type 1 diabetes.
Methods: A retrospective study of patients with type 1 diabetes who upgraded from basic predictive low-glucose systems (MiniMed 640G) to early automated systems (770G), and finally to advanced hybrid closed-loop systems (780G). Satisfaction levels and glucose data were thoroughly compared.
Main Findings: While basic daily satisfaction scores remained relatively steady, patients reported a dramatic boost in overall comparative satisfaction after upgrading to the 780G advanced hybrid closed-loop pump. Along with feeling more satisfied, patients experienced lower HbA1c levels and spent more "time in range" (stable blood sugar ranges).
Clinical Significance: Newer "smart" insulin pump systems that automate correction doses do not just improve clinical metrics; they dramatically reduce the mental burden of diabetes, directly resulting in happier, more satisfied patients.
Validating a Faster, Simpler Way to Diagnose Diabetic Nerve Damage
Authors: Tatsuhito Himeno, Hideki Kamiya, Yuka Shibata, Masato Kase, Hiromi Nakai‐Shimoda, Dai Yamagami, Masahiro Saito, Teruo Jojima, Aiko Arimura, Kenta Murotani, Chieko Suzuki, Hiroki Mizukami, Takahisa Deguchi, Yoshimasa Aso, Jiro Nakamura
Research Objective: To test if combining two rapid, simple tests—measuring minor variations in heart rate and using a quick hand-held nerve conduction device—can diagnose diabetic polyneuropathy (DPN) as accurately as complex, time-consuming hospital testing equipment.
Methods: A retrospective study of 314 patients compared results from classic, high-end electromyography machines against simple diagnostic tools: heart rate rhythm variation (CV_R-R) and a point-of-care nerve testing device (NC-stat/DPNCheck™).
Main Findings: Combining these two simple, quick tests provided diagnostic results that highly agreed with the older, complex, and expensive laboratory nerve conduction methods.
Clinical Significance: Objective nerve testing is vital because subjective symptoms do not always match actual physical nerve damage. Having a fast, reliable, and portable way to test nerves in ordinary clinics can help doctors spot and treat diabetic neuropathy years before it becomes severe.
